BioCentury
ARTICLE | Finance

Buyside Tracks

Biotech investor, banker and analyst personnel changes

March 14, 2011 7:00 AM UTC

William Brooks departed Quest Management, where he was the life sciences investment director. Quest is being acquired by Capricorn Venture Partners (see BioCentury, Jan. 10). ...